Recent systems biology and genome-wide association studies link EBF1 to various human cardiovascular diseases, such as coronary heart disease 19-22, cardiovascular metabolic disease 23 and orthostatic hypotension 24, implying its potential roles in the human cardiac system. Here, EBF1 is linked to coronary artery disorder.